Predictions
Mullen Automotive Inc.
Start price
Target price
Perf. (%)
€0.11
05.08.23
05.08.23
€0.000
05.08.24
05.08.24
-7.36%
20.11.23
20.11.23
Bad rating
Risky balance sheet
Increased challenges to pay loans and raise capital
Probably not worthwhile Investment
Transmedics Group Inc
Start price
Target price
Perf. (%)
€72.91
04.08.23
04.08.23
€99.72
04.08.24
04.08.24
59.17%
02.05.24
02.05.24
Avast Plc.
Start price
Target price
Perf. (%)
€8.01
03.08.23
03.08.23
€7.00
03.08.24
03.08.24
-
12.09.22
12.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Thyssenkrupp Nucera Ag&co.kgaa
Start price
Target price
Perf. (%)
€22.96
01.08.23
01.08.23
-
01.08.24
01.08.24
-46.21%
02.05.24
02.05.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€5.95
31.07.23
31.07.23
€31.73
31.07.24
31.07.24
83.19%
29.04.24
29.04.24
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€7.80
28.07.23
28.07.23
€9.99
28.07.24
28.07.24
46.47%
02.05.24
02.05.24
Gossamer Bio Inc.
Start price
Target price
Perf. (%)
€1.19
22.07.23
22.07.23
€3.00
31.05.26
31.05.26
-46.32%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year
Nikola Corp.
Start price
Target price
Perf. (%)
€2.23
22.07.23
22.07.23
€0.050
22.08.24
22.08.24
-74.18%
02.05.24
02.05.24
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad rating
Astria Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.86
20.07.23
20.07.23
€10.00
30.04.26
30.04.26
-3.50%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Antelope Enterprise Hldgs Ltd.
Start price
Target price
Perf. (%)
€0.58
14.07.23
14.07.23
€0.30
14.07.24
14.07.24
-51.72%
20.11.23
20.11.23
Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Claranova S.a.
Start price
Target price
Perf. (%)
€1.64
08.07.23
08.07.23
-
08.07.24
08.07.24
45.55%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Oric Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.70
26.06.23
26.06.23
€9.00
31.12.25
31.12.25
15.58%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year
Equillium Inc.
Start price
Target price
Perf. (%)
€0.64
24.06.23
24.06.23
€1.10
24.06.24
24.06.24
138.44%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
Ideaya Biosciences Inc.
Start price
Target price
Perf. (%)
€22.20
24.06.23
24.06.23
€37.00
31.12.25
31.12.25
68.47%
30.04.24
30.04.24
Could be very worthwhile Investment >20% year
Merus N.v.
Start price
Target price
Perf. (%)
€23.20
24.06.23
24.06.23
€40.00
30.04.26
30.04.26
77.59%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year
Legend Biotech Corp.
Start price
Target price
Perf. (%)
€66.00
24.06.23
24.06.23
€90.00
28.02.26
28.02.26
-36.06%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Roivant Sciences Ltd.
Start price
Target price
Perf. (%)
€9.00
24.06.23
24.06.23
€16.00
31.12.25
31.12.25
16.50%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year
Schrodinger Inc.
Start price
Target price
Perf. (%)
€39.18
24.06.23
24.06.23
€100.00
31.08.26
31.08.26
-44.87%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year